Cargando…
Apatinib inhibits the proliferation of gastric cancer cells via the AKT/GSK signaling pathway in vivo
Gastric cancer (GC) is the third leading cause of cancer-associated mortality globally. Although the diagnosis and therapeutic strategies for GC have improved, the prognosis for advanced gastric cancer (AGC) remains poor. Hence, the present study sought to design a zebrafish model established by mic...
Autores principales: | Chen, Yi, Chen, Nan, Xu, Jin, Wang, Xindong, Wei, Xiaowei, Tang, Cuiju, Duanmu, Zhong, Shi, Junfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436942/ https://www.ncbi.nlm.nih.gov/pubmed/34453028 http://dx.doi.org/10.18632/aging.203458 |
Ejemplares similares
-
Apatinib Mesylate Inhibits the Proliferation and Metastasis of Epithelioid Malignant Peritoneal Mesothelioma In Vitro and In Vivo
por: Yang, Zhi-Ran, et al.
Publicado: (2020) -
Apatinib Suppresses Gastric Cancer Stem Cells Properties by Inhibiting the Sonic Hedgehog Pathway
por: Cao, Wanshuang, et al.
Publicado: (2021) -
Downregulation of Annexin A11 (ANXA11) Inhibits Cell Proliferation, Invasion, and Migration via the AKT/GSK-3β Pathway in Gastric Cancer
por: Hua, Kelei, et al.
Publicado: (2018) -
Combined aspirin and apatinib treatment suppresses gastric cancer cell proliferation
por: Zhang, Wei, et al.
Publicado: (2017) -
Chrysomycin A Regulates Proliferation and Apoptosis of Neuroglioma Cells via the Akt/GSK-3β Signaling Pathway In Vivo and In Vitro
por: Liu, Dong-Ni, et al.
Publicado: (2023)